• 5690 Citations
  • 34 h-Index
19992019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Giovanni Mazzarol is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Sentinel Lymph Node Biopsy Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Breast Medicine & Life Sciences
Lymph Nodes Medicine & Life Sciences
Neoplasm Micrometastasis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2019

  • 5690 Citations
  • 34 h-Index
  • 92 Article
1 Citation (Scopus)

MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort

IMI Study Group, GEM Study Group & M-SKIP Study Group, May 1 2019, In : The Lancet Child and Adolescent Health. 3, 5, p. 332-342 11 p.

Research output: Contribution to journalArticle

Receptor, Melanocortin, Type 1
Melanoma
Genes
Odds Ratio
Serbia

MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort: The Lancet Child and Adolescent Health

IMI Study Group, the GEM Study Group, and the M-SKIP Study Group, 2019, In : Lancet Child Adolesc. Health. 3, 5, p. 332-342 11 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Atypical ductal hyperplasia: Our experience in the management and long term clinical follow-up in 71 patients

Latronico, A., Nicosia, L., Faggian, A., Abbate, F., Penco, S., Bozzini, A., Cannataci, C., Mazzarol, G. & Cassano, E., Feb 1 2018, In : Breast. 37, p. 1-5 5 p.

Research output: Contribution to journalArticle

Carcinoma, Intraductal, Noninfiltrating
Breast
Biopsy
Carcinoma
Incidence

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

International Breast Cancer Study Group Trial 23-01, Oct 1 2018, In : The Lancet Oncology. 19, 10, p. 1385-1393 9 p.

Research output: Contribution to journalArticle

Neoplasm Micrometastasis
Dissection
Breast Neoplasms
Disease-Free Survival
cyhalothrin
32 Citations (Scopus)

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

International Breast Cancer Study Group Trial 23-01, Oct 1 2018, In : The Lancet Oncology. 19, 10, p. 1385-1393 9 p.

Research output: Contribution to journalArticle

Neoplasm Micrometastasis
Dissection
Breast Neoplasms
Disease-Free Survival
cyhalothrin